TOMM34 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.386000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.079800E-01
Normal-vs-Stage2
3.500000E-01
Normal-vs-Stage3
7.709400E-01
Normal-vs-Stage4
1.953180E-01
Stage1-vs-Stage2
9.460400E-01
Stage1-vs-Stage3
2.728200E-01
Stage1-vs-Stage4
6.096000E-01
Stage2-vs-Stage3
1.620050E-01
Stage2-vs-Stage4
5.773000E-01
Stage3-vs-Stage4
1.464770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.385400E-01
Normal-vs-AfricanAmerican
3.429000E-01
Normal-vs-Asian
3.718400E-01
Caucasian-vs-AfricanAmerican
9.591200E-01
Caucasian-vs-Asian
8.754600E-01
AfricanAmerican-vs-Asian
8.800600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.210400E-01
Normal-vs-Female
3.739000E-01
Male-vs-Female
6.643000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.503800E-01
Normal-vs-Age(41-60Yrs)
2.003200E-01
Normal-vs-Age(61-80Yrs)
4.665600E-01
Normal-vs-Age(81-100Yrs)
2.679400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.589200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.628000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.673600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.304800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.903200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.734630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.399600E-01
Normal-vs-Daily Drinker
2.669400E-01
Normal-vs-Weekly Drinker
4.135800E-01
Normal-vs-Occasional Drinker
4.899900E-02
Normal-vs-Social Drinker
4.055600E-01
Non Drinker-vs-Daily Drinker
3.034200E-01
Non Drinker-vs-Weekly Drinker
3.756200E-01
Non Drinker-vs-Occasional Drinker
7.172400E-02
Non Drinker-vs-Social Drinker
9.732400E-01
Daily Drinker-vs-Weekly Drinker
9.169800E-01
Daily Drinker-vs-Occasional Drinker
4.583800E-01
Daily Drinker-vs-Social Drinker
3.091200E-01
Weekly Drinker-vs-Occasional Drinker
6.941400E-01
Weekly Drinker-vs-Social Drinker
4.175400E-01
Occasional Drinker-vs-Social Drinker
4.272200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.032800E-01
Normal-vs-Grade 2
7.557200E-01
Normal-vs-Grade 3
7.678400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.324300E-02
Grade 1-vs-Grade 3
7.080400E-02
Grade 1-vs-Grade 4
7.032800E-01
Grade 2-vs-Grade 3
6.531600E-01
Grade 2-vs-Grade 4
7.557200E-01
Grade 3-vs-Grade 4
7.678400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.805800E-01
Normal-vs-NonDiabetic
2.695000E-01
Diabetic-vs-NonDiabetic
9.532300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.272000E-02
Normal-vs-NoPancreatitis
3.497000E-01
Pancreatitis-vs-NoPancreatitis
2.344400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.569800E-01
Normal-vs-N1
3.695400E-01
N0-vs-N1
8.951000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.073440E-01
Normal-vs-TP53-NonMutant
5.742400E-01
TP53-Mutant-vs-TP53-NonMutant
1.15040000003841E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
